Pathology Trade Group 2nd To Sue FDA Over Lab-Test Rule

By Mark Payne · August 20, 2024, 3:41 PM EDT

A molecular pathology trade group has filed a lawsuit against the U.S. Food and Drug Administration, challenging a recent final rule to regulate laboratory-developed tests as medical devices and arguing the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Laposata et al v. United States Food and Drug Administration et al

Case Number

3:24-cv-00241

Court

Texas Southern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 19, 2024

Recent Articles By Mark

August 22, 2024
Texas Tells High Court It's Not Idaho '2.0' In HHS Abortion Row
August 14, 2024
Hospital Groups Tell High Court HHS 'Stingy' In SSI Pay Row
August 13, 2024
Test-Makers See Way Out Of FDA Rule With Chevron Reversal
August 13, 2024
As Attacks Rise, OSHA Lags On Health Workplace Protections
August 08, 2024
Hospitals Tell High Court HHS Errs In SSI Pay Formula
August 06, 2024
NC Hospital Gets New Shot At Emergency Dept. Plan Approval
August 06, 2024
CMS Signals States Can Dump Medical Debt After NC Consent
August 01, 2024
Hogan Lovells Recruits Two From Foley Hoag To Health Team
July 30, 2024
Life Sciences Cases To Watch 2024: A Midyear Report
July 23, 2024
On Capitol Hill, PBM Execs Deny Role In High Drug Costs